2022 Gradient Prize

We’re excited to announce the 2022 Gradient Prize sponsored by ImmunAI! TLDR: Submit full, finished pieces between Jan 1 and April 1, 2022 for a chance to win a total of $3000 in prizes — we can’t wait to see what you come up with!

To enter the contest, just fill out our writing interest form and indicate interest in the contest in your submission.

Prize allocation

In total, we will award $3000 in prizes for the best new article submissions received between Jan 1 and April 1, 2022.

  • Winner: $1500
  • Two runners-up: $750 each

Guidelines for a winning essay

The remainder of these should be considered rough, flexible guidelines for pieces that have been successful in the past. If you write something truly brilliant that contradicts these, please still feel free to submit!

Selection process

The process of selecting winners will be as follows.

  • The core team of Gradient editors will read all submissions and compile a shortlist of finalists. Each submission will be read by at least two members of Gradient editorial staff.
  • The shortlist of finalists will be anonymized and sent to our guest judge(s).

Immunai

Immunai is a techbio company (based in NYC and Tel Aviv) that uses single-cell genomics and machine learning to develop novel cancer and autoimmunity drugs and reprogram the immune system. Immunai has created a new systemic approach for drug discovery and development by building a proprietary platform that combines best-in-class single-cell genomic methods, artificial intelligence (based on tens of millions of cells and other data), and immunology. They are developing the first modern ML methods (think a “Cell BERT”) for cancer immunotherapy drug discovery, and their key advantage is ~ 10x more high-dimensional singe-cell data than most other methods (think ~ 1TB of data per 1 mL of blood).

Immunai’s team of ML Scientists and immunologists then uses this data to surface insights such as mechanisms of action and resistance, allowing the company to develop new therapies and evaluate and validate preclinical assets. For more information, visit www.immunai.com, or read one of their blogposts here.

Previous Winners

The 2021 Gradient prize was won by The Imperative for Sustainable AI Systems, with Machine Translation Shifts Power and Machine Learning Won't Solve Natural Language Understanding winning the runner up prizes.